Home › Funds › W.G. Shaheen & Associates DBA Whitney & Co › EW

W.G. Shaheen & Associates DBA Whitney & Co position in EW

EDWARDS LIFESCIENCES CORP · Health Care

W.G. Shaheen & Associates DBA Whitney & Co reported holding 178,438 shares of EW (EDWARDS LIFESCIENCES CORP) in its Q3 2026 13F filing — a position valued at US$15.4M, representing 1.10% of its reported portfolio and ranking #27 among its reported holdings. W.G. Shaheen & Associates DBA Whitney & Co has disclosed EW holdings in 9 of the last 9 reported quarters, going back to Q3 2024.

Latest position (Q3 2026)178.44K sh
Reported value held$15.40M
Portfolio Weight1.10%
First reportedQ3 2024
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How W.G. Shaheen & Associates DBA Whitney & Co's EW position evolved

W.G. Shaheen & Associates DBA Whitney & Co first disclosed a stake in EW in Q3 2024 at 110,477 shares (US$7.3M). The position peaked in Q2 2026 at 177,463 shares, worth US$16.1M. Across 9 filings, W.G. Shaheen & Associates DBA Whitney & Co increased the stake 8 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 178,438 shares valued at US$15.4M — an increase of 975 shares quarter over quarter.. Notable position changes include a 46% increase in Q4 2024 (shares fell 2% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2024 110.48K $7.29M New
Q4 2024 161.22K $11.94M Add
Q1 2025 166.68K $12.08M Add
Q2 2025 168.17K $13.15M Add
Q3 2025 169.58K $13.19M Add
Q4 2025 170.88K $14.57M Add
Q1 2026 173.75K $13.91M Add
Q2 2026 177.46K $16.05M Add
Q3 2026 178.44K $15.40M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About EW and 13F data

EW (EDWARDS LIFESCIENCES CORP) is a Health Care company. 31 other funds we track also report a position in EW — the largest reported positions include Belvedere Trading LLC (US$25.63B), DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt (US$1.18B), Ninety One UK Ltd (US$1.03B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding EW

All EW fund holders →

FAQ

How long has W.G. Shaheen & Associates DBA Whitney & Co held EW?

W.G. Shaheen & Associates DBA Whitney & Co has disclosed EW holdings in 9 of the last 9 reported quarters, going back to Q3 2024.

What is W.G. Shaheen & Associates DBA Whitney & Co's current position in EW?

As of Q3 2026, W.G. Shaheen & Associates DBA Whitney & Co holds 178.44K shares of EW (EDWARDS LIFESCIENCES CORP), valued at $15.40M, representing 1.10% of its reported portfolio and ranking #27.

Has W.G. Shaheen & Associates DBA Whitney & Co been buying or selling EW?

In the latest 13F filing (Q3 2026), W.G. Shaheen & Associates DBA Whitney & Co increased its position in EW. The position peaked in Q2 2026 at 177.46K shares.

Which other funds hold EW?

Other major institutional holders of EW include Belvedere Trading LLC, DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt, Ninety One UK Ltd, among 31 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.